Seoul National University Bundang Hospital (SNUBH)
Glioblastoma treatment cost in South Korea typically depends on the surgical complexity and the specific radiation technology used. Initial diagnostics like a brain MRI with contrast run from AUD $1,009 to AUD $1,730, while procedures like Gamma Knife surgery cost between AUD $19,463 and AUD $27,681. Patients save around 30–50% compared to Australia or the US, with most major treatment centres located in Seoul.
Typical Glioblastoma Treatment Costs in South Korea
Bookimed Expert Insight: Patients with complex tumours benefit from multidisciplinary teams at large Seoul centres. Asan Medical Center, for example, is the largest multidisciplinary facility in South Korea and manages over 10,000 outpatients daily. This high volume means surgeons handle complex cases routinely. For those requiring advanced precision, Korea University Anam Hospital specialises in robotic techniques and minimal blood transfusion methods to improve recovery.
| Republic of Korea | Thailand | Turkey | |
| Gamma Knife | from AUD $19,463 | from AUD $36,043 | from AUD $9,083 |
| Chemotherapy for breast cancer | from AUD $27,681 | from AUD $4,325 | from AUD $1,730 |
| Resection of glioblastoma | - | - | from AUD $20,761 |
| Halcyon | - | - | from AUD $7,785 |
| Actinium-225 Therapy | - | from AUD $36,043 | from AUD $33,095 |
No hidden fees – just official clinic prices. Pay at the clinic for Glioblastoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
Professor Do Hyun Nam leads the neuro-oncology team at Samsung Medical Center, specialising in surgical removal of brain tumours in both adults and children.
Top Republic of Korea hospitals follow a multimodal protocol. This starts with maximum surgical resection, followed by six weeks of chemo-radiotherapy and maintenance chemotherapy. JCI-accredited centres like Severance Hospital use 5-ALA fluorescence-guided surgery to identify and remove invasive tumour cells while sparing critical brain tissue.
Bookimed Expert Insight: Republic of Korea maintains some of the most densely digitalised health systems. Facilities like Seoul National University Hospital and its Bundang branch use integrated electronic patient records to coordinate multidisciplinary teams. This digital infrastructure helps specialists across neuro-oncology and radiation oncology track results in real-time. This level of coordination is vital for glioblastoma cases. It allows treatment sequencing to be adjusted immediately after high-volume surgeries.
Patient Consensus: Patients note that care in Republic of Korea is managed by multidisciplinary teams. They highlight the importance of asking for molecular profiling and clinical trial options after the initial surgery.
Glioblastoma treatments like immunotherapy and clinical trials are accessible at major tertiary hospitals in Seoul. Leading centres like Seoul National University Hospital (SNUH) and Severance Hospital host trials. These trials cover recurrent and newly diagnosed cases. Access depends on molecular markers and specific trial eligibility.
Bookimed Expert Insight: South Korea's glioblastoma care is highly concentrated in Seoul. SNUH alone serves 10,700 patients daily. Our data shows that 76 clinics operate in the region. Only large university hospitals like SNUH or Severance offer molecular profiling for trial eligibility. Australian patients should have their pathology and MRI files professionally translated before arrival. This helps speed up the screening process for limited trial spots.
Patient Consensus: Patients find that experimental treatments in South Korea are best accessed through larger academic hospitals. Practical barriers like trial eligibility mean preparing detailed medical records is essential for Australian patients. Having a local advocate also helps during the process.
South Korean glioblastoma treatment follows international protocols within JCI-accredited and Newsweek-ranked facilities. Specialised neuro-oncology teams use fluorescence-guided resection to remove 95% of brain tumours effectively. Patients receive radiotherapy and temozolomide chemotherapy at major centres including Asan Medical Center and Severance Hospital.
Bookimed Expert Insight: South Korea's glioblastoma care excels due to high patient volumes and digital infrastructure. Seoul National University Bundang Hospital serves 1.5 million patients yearly with a digital system. This high-volume environment helps specialists refine precision techniques like fluorescence-guided surgery. This expertise often leads to higher success rates in preserving healthy brain tissue.
Patient Consensus: Patients find the technology and the speed of treatment preparation impressive in South Korea. They value the clear communication about surgical risks and the organised post-operative care.
South Korean tertiary centres provide integrated neuro-rehabilitation and adjuvant therapy monitoring for glioblastoma patients. Care includes immediate post-operative MRI scans, daily physical therapy, and cognitive support. Facilities like Severance Hospital and Seoul National University Hospital coordinate these multi-disciplinary programs.
Bookimed Expert Insight: Korea University Anam Hospital uses minimal blood transfusion techniques. This approach often helps patients transition into active rehabilitation sooner. When choosing a clinic, patients should look for those with over 60,000 annual operations. This indicates the scale needed to support complex neuro-rehabilitation teams.
Patient Consensus: Patients in the Republic of Korea recommend confirming the specifics of neuro-rehabilitation before arrival. Many note the importance of a clear plan for handover to Australian GPs for ongoing steroid and seizure management.
Specialists in the Republic of Korea manage glioblastoma by integrating maximal safe resection with structured rehabilitation. They use fluorescence-guided imaging to preserve healthy brain tissue during surgery. This approach reduces neurological deficits. Multidisciplinary teams and digital health systems further help maintain patient safety and daily function.
Bookimed Expert Insight: South Korea's glioblastoma care stands out due to its high level of digitisation. Hospitals like Seoul National University Hospital (SNUH) and SNUBH have used digital patient records for over 20 years. This long-term data tracking allows multidisciplinary teams to adjust rehabilitation plans instantly. For patients, this means faster transitions from surgery to supportive therapy. This is critical for preserving speech and motor skills.
Neuro-oncology specialist teams in South Korea are structured within multidisciplinary academic hubs. These teams integrate neurosurgeons, medical oncologists, and radiation oncologists to manage complex brain cancers. Major Seoul-based centres use tools like Gamma Knife radiosurgery and fluorescence-guided surgery to treat glioblastoma.
Bookimed Expert Insight: While many countries have oncology units, South Korea's model is uniquely digitalised. Centres like Seoul National University Bundang Hospital use the BESTcare system to reduce medical errors. This digital approach supports surgical teams in handling high patient volumes. Some hospitals treat over 1,000,000 patients annually.